| PCS-2023 > 3 > 3E > 3E0 > 3E03 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E03 | Introduction, Peripheral Vein | |
3E030 | Open | |
3E0300 | Antineoplastic | |
3E03002 | Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach | |
3E03003 | Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach | |
3E03005 | Introduction of Other Antineoplastic into Peripheral Vein, Open Approach | |
3E0300M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach | |
3E0300P | Introduction of Clofarabine into Peripheral Vein, Open Approach | |
3E0301 | Thrombolytic | |
3E03016 | Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open | |
3E03017 | Introduction of Other Thrombolytic into Peripheral Vein, Open Approach | |
3E0302 | Anti-infective | |
3E03028 | Introduction of Oxazolidinones into Peripheral Vein, Open Approach | |
3E03029 | Introduction of Other Anti-infective into Peripheral Vein, Open Approach | |
3E0303 | Anti-inflammatory | |
3E0303Z | Introduction of Anti-inflammatory into Peripheral Vein, Open Approach | |
3E0304 | Serum, Toxoid and Vaccine | |
3E0304Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach | |
3E0306 | Nutritional Substance | |
3E0306Z | Introduction of Nutritional Substance into Peripheral Vein, Open Approach | |
3E0307 | Electrolytic and Water Balance Substance | |
3E0307Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach | |
3E030F | Intracirculatory Anesthetic | |
3E030FZ | Introduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach | |
3E030H | Radioactive Substance | |
3E030HZ | Introduction of Radioactive Substance into Peripheral Vein, Open Approach | |
3E030K | Other Diagnostic Substance | |
3E030KZ | Introduction of Other Diagnostic Substance into Peripheral Vein, Open Approach | |
3E030N | Analgesics, Hypnotics, Sedatives | |
3E030NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach | |
3E030P | Platelet Inhibitor | |
3E030PZ | Introduction of Platelet Inhibitor into Peripheral Vein, Open Approach | |
3E030R | Antiarrhythmic | |
3E030RZ | Introduction of Antiarrhythmic into Peripheral Vein, Open Approach | |
3E030T | Destructive Agent | |
3E030TZ | Introduction of Destructive Agent into Peripheral Vein, Open Approach | |
3E030X | Vasopressor | |
3E030XZ | Introduction of Vasopressor into Peripheral Vein, Open Approach | |
3E030G | Other Therapeutic Substance | |
3E030GC | Introduction of Other Therapeutic Substance into Peripheral Vein, Open Approach | |
3E030GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach | |
3E030U | Pancreatic Islet Cells | |
3E030U0 | Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach | |
3E030U1 | Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach | |
3E030V | Hormone | |
3E030VG | Introduction of Insulin into Peripheral Vein, Open Approach | |
3E030VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach | |
3E030VJ | Introduction of Other Hormone into Peripheral Vein, Open Approach | |
3E030W | Immunotherapeutic | |
3E030WK | Introduction of Immunostimulator into Peripheral Vein, Open | |
3E030WL | Introduction of Immunosuppressive into Peripheral Vein, Open | |
3E033 | Percutaneous | |
3E0330 | Antineoplastic | |
3E03302 | Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach | |
3E03303 | Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach | |
3E03305 | Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach | |
3E0330M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach | |
3E0330P | Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach | |
3E0331 | Thrombolytic | |
3E03316 | Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous | |
3E03317 | Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach | |
3E0332 | Anti-infective | |
3E03328 | Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach | |
3E03329 | Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach | |
3E0333 | Anti-inflammatory | |
3E0333Z | Introduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach | |
3E0334 | Serum, Toxoid and Vaccine | |
3E0334Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach | |
3E0336 | Nutritional Substance | |
3E0336Z | Introduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach | |
3E0337 | Electrolytic and Water Balance Substance | |
3E0337Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach | |
3E033F | Intracirculatory Anesthetic | |
3E033FZ | Introduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach | |
3E033H | Radioactive Substance | |
3E033HZ | Introduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach | |
3E033K | Other Diagnostic Substance | |
3E033KZ | Introduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach | |
3E033N | Analgesics, Hypnotics, Sedatives | |
3E033NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach | |
3E033P | Platelet Inhibitor | |
3E033PZ | Introduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach | |
3E033R | Antiarrhythmic | |
3E033RZ | Introduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach | |
3E033T | Destructive Agent | |
3E033TZ | Introduction of Destructive Agent into Peripheral Vein, Percutaneous Approach | |
3E033X | Vasopressor | |
3E033XZ | Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach | |
3E033G | Other Therapeutic Substance | |
3E033GC | Introduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach | |
3E033GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach | |
3E033GQ | Introduction of Glucarpidase into Peripheral Vein, Percutaneous Approach | |
3E033GR | Introduction of Other Therapeutic Monoclonal Antibody into Peripheral Vein, Percutaneous Approach | |
3E033U | Pancreatic Islet Cells | |
3E033U0 | Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach | |
3E033U1 | Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach | |
3E033V | Hormone | |
3E033VG | Introduction of Insulin into Peripheral Vein, Percutaneous Approach | |
3E033VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach | |
3E033VJ | Introduction of Other Hormone into Peripheral Vein, Percutaneous Approach | |
3E033W | Immunotherapeutic | |
3E033WK | Introduction of Immunostimulator into Peripheral Vein, Percutaneous | |
3E033WL | Introduction of Immunosuppressive into Peripheral Vein, Percutaneous | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |